Tenacissoside G

CAS No. 191729-43-8

Tenacissoside G( —— )

Catalog No. M18173 CAS No. 191729-43-8

Tenacissoside G is a C21 steroid from the stems of Marsdenia tenacissima.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 140 In Stock
25MG 235 In Stock
50MG 350 In Stock
100MG 516 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tenacissoside G
  • Note
    Research use only, not for human use.
  • Brief Description
    Tenacissoside G is a C21 steroid from the stems of Marsdenia tenacissima.
  • Description
    Tenacissoside G is a C21 steroid from the stems of Marsdenia tenacissima. Tenacissoside G reverses multidrug resistance in P-glycoprotein (Pgp)-overexpressing multidrug-resistant cancer cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    191729-43-8
  • Formula Weight
    792.96
  • Molecular Formula
    C42H64O14
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (126.11 mM)
  • SMILES
    CC=C(C)C(=O)OC1C2C3(CCC(CC3CCC24C5(O4)CCC(C5(C1OC(=O)C)C)C(=O)C)OC6CC(C(C(O6)C)OC7C(C(C(C(O7)C)O)OC)O)OC)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 16,17-Epoxypregnenol

    16,17-Epoxypregnenol

  • MAPK13-IN-1

    MAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).

  • PAF (C16)

    PAF (C16) is a potent MAPK and MEK/ERK activator that induces increased vascular permeability. PAF (C16) (PAF (C16)) is a platelet-activating factor, a phospholipid-derived mediator and a ligand for PAF G protein-coupled receptor (PAFR). PAF (C16) has shown anti-apoptotic and anti-inflammatory activity in vitro, inhibiting Caspase-dependent apoptosis by interacting with its receptor (PAF-R) to perform cell signaling.